Evidence reviewed: 8 November 2026. Anxiety disorders involve persistent or recurrent fear, worry or avoidance that causes meaningful distress or interferes with daily activities. Anxiety itself is a normal protective response; a disorder is not diagnosed simply because someone feels worried. Common conditions include generalized anxiety disorder (GAD), panic disorder, social anxiety disorder, specific phobias and agoraphobia. Treatment depends on the condition but often centers on cognitive behavioral therapy (CBT), appropriately selected antidepressants, and reduction of avoidance. The NICE CG113 guidance recommends a stepped approach for GAD and panic disorder and discourages routine benzodiazepines for chronic anxiety [1–3].
When does anxiety become a disorder?
Most people feel anxious before an exam, a medical appointment or a difficult conversation. Clinical anxiety disorders involve excessive fear or worry relative to the situation, persistent symptoms, difficulty controlling the response and impairment. Anxiety may lead to avoidance of work, study, relationships or necessary medical care. The exact diagnostic criteria and duration vary by condition [1,2].
Generalized anxiety disorder usually involves excessive anxiety and worry across several areas of life on most days for at least six months, with symptoms such as restlessness, tension, fatigue, irritability, concentration problems or sleep disturbance. Panic disorder involves unexpected panic attacks with persistent worry or maladaptive behavior change. Social anxiety disorder centers on negative evaluation in social situations; specific phobias involve particular objects or circumstances [1–3].
Recognizing symptoms
| Emotional/cognitive symptoms | Physical or behavioral symptoms |
|---|---|
| Excessive worry and difficulty tolerating uncertainty. | Muscle tension, headache, jaw clenching or restlessness. |
| Persistent expectation that something bad will happen. | Palpitations, sweating, trembling or stomach discomfort. |
| Difficulty concentrating because of worry. | Sleep disruption, fatigue or a constant sense of being on edge. |
| Fear of embarrassment or losing control. | Avoiding social events, transport, medical visits or other feared situations. |
| Repeated requests for reassurance or checking. | Excessive internet searching, procrastination or reliance on alcohol or sedatives. |
Physical symptoms are not proof of a psychiatric cause. A new racing heart, breathlessness, chest pain or fainting may require evaluation for a cardiac, respiratory or metabolic condition. Serious chest pain, collapse or severe breathlessness is an emergency, not something to treat with relaxation exercises alone.
Types of anxiety disorders
| Disorder | Typical core feature | Common effective approach |
|---|---|---|
| Generalized anxiety disorder (GAD) | Broad, difficult-to-control worry across several domains. | GAD-focused CBT or applied relaxation; SSRIs/SNRIs for selected adults. |
| Panic disorder | Unexpected panic attacks and fear or avoidance related to further attacks. | CBT with interoceptive exposure; selected antidepressants. |
| Social anxiety disorder | Fear of being judged or embarrassed socially. | Disorder-specific CBT with behavioral experiments; SSRIs for some adults. |
| Specific phobia | Intense, disproportionate fear of a particular stimulus. | Graded exposure-based psychological treatment. |
| Agoraphobia | Fear of situations where escape or obtaining help could be difficult. | CBT with carefully planned exposure and functional recovery. |
Obsessive-compulsive disorder (OCD) and PTSD have overlapping anxiety symptoms but are classified separately and have their own evidence-based treatment protocols. For detailed approaches, see our OCD treatment guide, PTSD guide and social anxiety guide.
What contributes to anxiety disorders?
Anxiety reflects interacting genetic vulnerability, brain threat-response networks, learning, stressful events, personality factors, sleep, physical health and environment. GABA, serotonin, norepinephrine and other signaling systems are involved, but no single neurotransmitter imbalance explains all anxiety disorders. Effective psychological treatment changes how individuals interpret, tolerate and respond to feared experiences [2,3].
Some medicines and substances can aggravate anxiety, including stimulants, excessive caffeine, nicotine, some asthma medicines, corticosteroids or withdrawal from sedatives or alcohol. Drug effects should be discussed with clinicians rather than assuming anxiety has only one cause.
How is anxiety diagnosed?
Assessment considers the pattern and duration of fear, triggers, avoidance, impairment, medical history, substance use, sleep and coexisting mental-health conditions. The GAD-7 questionnaire can help screen and monitor symptoms, but a score alone does not diagnose GAD [1].
Where indicated, clinicians assess conditions such as hyperthyroidism, arrhythmia, asthma, anemia, hypoglycemia or medication effects. They also evaluate depression, substance-use disorders, bipolar symptoms and suicide risk when relevant. Broad repeated tests without clinical indications can increase anxiety rather than help.
First-line treatment: CBT and exposure
CBT is a core evidence-based treatment across several anxiety disorders. It may address catastrophic predictions, avoidance, safety behaviors, worry cycles and intolerance of uncertainty. Exposure-based methods help patients gradually face reasonably safe feared situations without relying on avoidance and ritualized reassurance [1–3].
In GAD, techniques often include structured work with worry, problem-solving, attention and behavioral experiments. For panic disorder, interoceptive exposure helps reduce fear of harmless bodily sensations after relevant medical evaluation. For social anxiety, behavioral experiments and reducing self-focused attention may be central.
Exposure therapy does not mean exposing patients to real danger. It is collaborative, graded and adapted to medical conditions, trauma history and preferences. Repeated forced humiliation or unsafe situations are not appropriate therapy.
NICE’s stepped-care approach for GAD
The NICE CG113 guideline recommends using the least intrusive effective intervention appropriate for symptom burden [1]:
- Identification, assessment and education: discuss GAD and review relevant health or social factors.
- Low-intensity psychological intervention: guided self-help, appropriate structured self-help or psychoeducation for persistent symptoms.
- Higher-intensity treatment: GAD-specific CBT or applied relaxation, or medication, where functioning is substantially affected.
- Specialist multidisciplinary care: for treatment-resistant or complex GAD, major impairment or high safety risks.
Choice should incorporate patient preference and prior response. A person who declines one treatment may still benefit from another. Access to qualified CBT or validated remote care can affect the practical plan.
SSRIs and SNRIs for anxiety disorders
Selective serotonin reuptake inhibitors (SSRIs) are frequently used when pharmacotherapy is appropriate. For GAD, NICE recommends considering an SSRI first, with sertraline often discussed due to clinical and cost-effectiveness; licensing varies. If that agent is ineffective or not tolerated, another SSRI or an SNRI may be considered [1].
| Medicine class | Examples | Important cautions |
|---|---|---|
| SSRIs | Sertraline, escitalopram, fluoxetine, paroxetine, others according to indication. | Initial agitation, nausea, sleep effects, sexual dysfunction, withdrawal symptoms and interactions. |
| SNRIs | Venlafaxine, duloxetine in appropriate disorders. | Blood-pressure effects, GI symptoms, sweating and discontinuation concerns. |
| Pregabalin | Sometimes considered for GAD when SSRIs/SNRIs are not tolerated. | Sleepiness, dizziness, misuse/dependence potential and important pregnancy precautions. |
| Benzodiazepines | Diazepam, lorazepam, alprazolam, others. | Not recommended for routine GAD treatment; addiction, sedation and withdrawal risks. |
| Propranolol or other beta blockers | Selected peripheral performance symptoms in certain cases. | Not a standard treatment for chronic GAD; contraindications such as asthma or bradycardia. |
SSRIs/SNRIs usually require several weeks for sustained improvement and can temporarily increase anxiety, restlessness or insomnia early in therapy. Doctors should monitor symptoms, tolerability, suicidal thinking in appropriate populations and interactions. Do not self-prescribe or increase doses because of an acute stressful day.
When can pregabalin be considered?
For GAD when SSRIs or SNRIs cannot be tolerated, NICE suggests considering pregabalin in an appropriate patient [1]. It acts by binding the alpha-2-delta subunit of voltage-gated calcium channels, reducing release of certain excitatory neurotransmitters; it does not work simply by “replacing GABA.”
Pregabalin can cause dizziness, sedation, weight gain, edema, misuse and dependence. There are specific pregnancy safety concerns, and additive respiratory/sedation risks when combined with opioids or other CNS depressants. Controlled-substance requirements vary by jurisdiction. It is not the first treatment for every anxiety symptom.
Why are benzodiazepines discouraged long-term?
Benzodiazepines enhance GABA-A receptor signaling and can rapidly reduce anxiety, but regular use may cause tolerance, physical dependence, withdrawal, cognitive impairment, falls and dangerous sedation with alcohol or opioids. NICE advises not to offer them for GAD except as a short-term measure during crises [1].
Do not abruptly stop an established regular benzodiazepine prescription. Withdrawal can include severe anxiety, insomnia and seizures; a clinician-guided taper may be necessary. Short-term specialist uses in unusual settings should not be portrayed as a cure for chronic anxiety or panic disorder.
What about buspirone, hydroxyzine and herbal medicines?
Buspirone, a 5-HT1A receptor partial agonist, is approved in some countries for anxiety disorders and may be considered by clinicians for selected patients, but its evidence and placement differ across guidelines. It is not an instant rescue medication. Hydroxyzine can reduce anxiety temporarily through antihistamine effects but has sedation and QT-related risks; it is not routine long-term therapy for all GAD patients.
Supplements such as kava, valerian, ashwagandha and unregulated “calming blends” have varying and often limited evidence, with possible liver toxicity, interactions or product-quality problems. They should not replace appropriate psychological or medical care [2].
Daily strategies that can support recovery
- Keep a predictable sleep–wake routine and investigate persistent insomnia or sleep apnea.
- Reduce excessive caffeine and stimulants if they aggravate symptoms.
- Engage in regular physical activity appropriate for health and capacity.
- Practice gentle, comfortable breathing and grounding during known anxiety episodes; avoid forced hyperventilation.
- Break difficult tasks into small manageable steps and reduce avoidance gradually.
- Seek social support and address practical stressors where possible.
- Avoid relying on alcohol, nicotine, cannabis or unprescribed sedatives as coping tools.
These strategies are adjuncts, not proof that medication or CBT is unnecessary. The best plan helps the person re-enter valued activities instead of merely trying to eliminate every anxious feeling.
Panic attacks versus persistent worry
Panic attacks cause a sudden intense surge of fear with physical sensations often peaking within minutes, while GAD involves more continuous difficult-to-control worry across multiple topics. The two can coexist, but treatment may differ. New severe chest pain, fainting or difficulty breathing should be assessed medically rather than assumed to be panic.
Our companion panic attacks and panic disorder guide explains emergency symptoms, interoceptive exposure and treatment in more detail.
Children, pregnancy and other special circumstances
In children and adolescents, age-appropriate CBT and family involvement are often central, and medication decisions require specialist pediatric guidance. Pregnancy and breastfeeding require individualized evaluation because some medicines may be unsuitable and untreated severe anxiety can also harm wellbeing.
Older adults may be more vulnerable to falls, confusion, hyponatremia and drug interactions. Medical comorbidities, kidney function and multiple prescriptions influence medicine choice. Do not abruptly stop prescribed anxiety or psychiatric medications when pregnancy is discovered; contact the prescriber to review risks and alternatives.
When should someone seek urgent support?
Seek urgent psychiatric care for suicidal intent, inability to remain safe, psychosis or extreme self-neglect. Medical red flags include new chest pain, severe dyspnea, collapse, a focal neurological deficit or rapidly progressive illness. Such events need evaluation even if the person has a history of anxiety.
Frequently asked questions
Does everyone who worries have an anxiety disorder?
No. Anxiety becomes a disorder when its pattern, duration and impairment meet clinical criteria.
Can GAD be diagnosed using GAD-7 alone?
No. The GAD-7 is a screening/monitoring aid, not a standalone diagnosis.
Is CBT as important as medication?
Yes. Condition-specific CBT is evidence-based and often a preferred treatment [1].
Are benzodiazepines safe to take every day for years?
Long-term regular use can create dependence and other harms; NICE discourages routine use for GAD [1].
Is propranolol the best treatment for generalized anxiety?
No. It may reduce selected performance-related physical symptoms, but it is not an established primary treatment for GAD.
Can anxiety cause physical symptoms?
Yes. However, new or severe symptoms must be assessed to exclude medical causes.
Key takeaways
Anxiety disorders are treatable and are not all the same condition. Use accurate diagnosis, evidence-based CBT and suitably selected medicines. SSRIs or SNRIs may help persistent GAD; avoid routine reliance on benzodiazepines and distinguish true medical emergencies from familiar anxiety symptoms.
References
- National Institute for Health and Care Excellence. Generalised anxiety disorder and panic disorder in adults: management (CG113). NICE; accessed 8 Nov 2026.
- National Institute of Mental Health. Generalized anxiety disorder: when worry gets out of control. NIH; accessed 8 Nov 2026.
- World Health Organization. Anxiety disorders: fact sheet. Accessed 8 Nov 2026.
- National Institute for Health and Care Excellence. Social anxiety disorder: recognition, assessment and treatment (CG159). NICE.
Medical disclaimer: Educational information only. Anxiety diagnosis and prescription treatment require individualized professional assessment. Never stop benzodiazepines or antidepressants abruptly. New severe chest pain, collapse, dangerous breathlessness or imminent psychiatric safety concerns require emergency evaluation.
Medical & AI Disclaimer
The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.
We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.